Acme's Mannitol Injection 20% is a sterile intravenous solution containing Mannitol 20% w/v, formulated for use as an osmotic diuretic. It is widely utilized in hospital and critical care settings to reduce increased intracranial and intraocular pressure and to promote diuresis in specific clinical conditions. The injection is prepared under strict quality standards to ensure safety, purity, and effectiveness.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Each 100 ml of solution contains:
Mannitol 20 g
Water for Injection q.s.
The solution is sterile, non-pyrogenic, and intended for intravenous infusion only.
Osmotic diuretic
Intravenous infusion
Acme's Mannitol Injection 20% is indicated for:
Reduction of raised intracranial pressure and cerebral edema
Lowering elevated intraocular pressure before ophthalmic procedures
Promotion of diuresis in acute renal failure
Prevention and treatment of acute kidney injury in selected cases
Enhancement of urinary excretion of toxic substances
It is commonly used in neurosurgical, ophthalmic, and critical care settings under close medical supervision.
Mannitol is a non-metabolizable sugar alcohol that acts as an osmotic diuretic. When administered intravenously, it increases plasma osmolarity, drawing water from tissues into the intravascular compartment. This action helps reduce cerebral and ocular edema.
In the kidneys, mannitol is freely filtered by the glomeruli and not reabsorbed by the renal tubules. It increases osmotic pressure within the renal tubules, thereby inhibiting water reabsorption and promoting increased urine output. This diuretic effect helps flush the kidneys and maintain renal function in specific clinical situations.
The dosage and infusion rate of Acme's Mannitol Injection 20% depend on the patient’s age, body weight, clinical condition, and therapeutic indication. Administration must be carried out by trained healthcare professionals. Adequate hydration and continuous monitoring of renal function, fluid balance, serum electrolytes, and serum osmolality are essential during therapy.
For intravenous use only under strict medical supervision.
Contraindicated in patients with severe dehydration, anuria, active intracranial bleeding, or severe pulmonary congestion.
Use with caution in patients with impaired renal function or heart failure.
Rapid infusion may cause fluid and electrolyte imbalance or circulatory overload.
Possible adverse effects include:
Electrolyte imbalance
Dehydration
Headache, nausea, or vomiting
Fluid overload and pulmonary edema in susceptible patients
Local infusion site reactions
If adverse reactions occur, the infusion should be adjusted or discontinued as advised by a physician.
Store below 30°C in a cool, dry place. Protect from freezing and direct sunlight. Do not use if the solution is cloudy or crystals persist after warming to room temperature.
Login Or Registerto submit your questions to seller
No none asked to seller yet